SteriLumen is a Health Care startup founded in 2016 with the mission of providing innovative disinfection solutions. Their patented products utilize germicidal UVC in various automated and connected designs, aiming to address the critical disinfection needs across various industries. Their focus on creating safe environments without emitting ozone or other harmful chemicals aligns with their commitment to environmental sustainability.
In 2020, SteriLumen strategically partnered with Akida LLC, the creators of the NASA-commissioned Airocide™ product line, to combat airborne pathogens, particularly in the fight against the coronavirus. This collaboration showcases their dedication to leveraging advanced technology to lower the risk of infection and control outbreaks, enabling businesses to resume operations safely. As a wholly owned subsidiary of Applied UV Inc. (NASDAQ:AUVI), SteriLumen has access to a broader network and resources to drive their growth and impact in the market.
Overall, SteriLumen's strategic partnerships, focus on cutting-edge technology, and commitment to infection control highlight the potential for further growth and impact, especially in light of the ongoing global health challenges.